At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wound Healing Endpoint and Recurrence
In Brief
A Phase 2 clinical trial evaluating Epiceram Skin Barrier Function and Vaseline Petroleum Jelly for Chronic Wound and 6 related conditions. Active but no longer recruiting, targeting 100 participants across 3 sites.
Detailed Summary
This study is a continuation of a previously approved protocol conducted at Ohio State University and Indiana University. The first two aims of the original protocol have been completed, and this protocol will finish enrollment for the third aim, comparing Hi TEWL and Low TEWL measurements, and whether a HiTEWLmeasurement indicates a seemingly healed wound is more likely to recur/reopen toa new wound. Of the 105 desired subjects, 62 subjects have already been recruited and completed their study participation at the previous university. 43 additional subjects will be recruited to complete the enrollment goal here at the University of Pittsburgh.
Study Details
Timeline
Interventions
Epiceram is a non-sterile, viscous, lipid-rich emulsion
A skin protectant used for temporarily protecting minor cuts, scraps, burns, and helps to protect and help relieve chapped or cracked skin and lips.